Literature DB >> 33243735

[Expression of CDC25A in non-small cell lung cancer and its relationship with let-7 gene].

Dianming Li1, Zhaofei Liu2, Guolan Ning3.   

Abstract

OBJECTIVE: To investigate the expression of CDC25A in non- small cell lung cancer (NSCLC) tissues and explore its correlation with the clinicpathological features of the patients and the expressions of let-7a1 and let-7c.
METHODS: We collected surgical specimens of pathologically confirmed NSCLC tissues and paired adjacent lung tissues from 44 patients and tissues of benign lung lesions from 9 patients. The expressions of CDC25A protein and mRNA in the tissues were detected by immunohistochemistry and fluorescence quantitative RT-PCR, respectively; the expressions of let-7a1 and let-7c mRNA were detected using tail-adding fluorescence quantitative RT-PCR.
RESULTS: The positivity rate of CDC25A protein expression was significantly higher in NSCLC tissues than in the adjacent tissues and benign pulmonary lesions (P < 0.05). CDC25A protein expression in NSCLC was not correlated with the patients' age, gender, pathological type, degree of tumor differentiation, or clinical stages (P > 0.05), and was significantly correlated with smoking and lymph node metastasis (P < 0.05). CDC25A mRNA expression was also significantly higher in NSCLC tissues than in the adjacent tissues and benign pulmonary lesions (F=6.33, P < 0.05), and was similar between the latter two tissues (P > 0.05). Pearson correlation analysis showed that CDC25A expression had a significant negative correlation with let-7c expression in both NSCLC tissues (r=-0.42) and adjacent lung tissues (r=-0.40) but was not correlated with let-7a1 expression.
CONCLUSIONS: The expression level of CDC25A is significantly increased in NSCLC with a negative correlation with Let-7c expression, which identifies CDC25A as a possible downstream target gene of Let-7c.

Entities:  

Keywords:  CDC25A; let-7; microRNA; non-small cell lung cancer

Mesh:

Substances:

Year:  2020        PMID: 33243735      PMCID: PMC7704372          DOI: 10.12122/j.issn.1673-4254.2020.11.13

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  25 in total

1.  Distinct modes of deregulation of the proto-oncogenic Cdc25A phosphatase in human breast cancer cell lines.

Authors:  Harald Löffler; Randi G Syljuåsen; Jirina Bartkova; Jesper Worm; Jiri Lukas; Jiri Bartek
Journal:  Oncogene       Date:  2003-11-06       Impact factor: 9.867

2.  The colorectal microRNAome.

Authors:  Jordan M Cummins; Yiping He; Rebecca J Leary; Ray Pagliarini; Luis A Diaz; Tobias Sjoblom; Omer Barad; Zvi Bentwich; Anna E Szafranska; Emmanuel Labourier; Christopher K Raymond; Brian S Roberts; Hartmut Juhl; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

3.  Anti-Colon Cancer Effects of 6-Shogaol Through G2/M Cell Cycle Arrest by p53/p21-cdc2/cdc25A Crosstalk.

Authors:  Lian-Wen Qi; Zhiyu Zhang; Chun-Feng Zhang; Samantha Anderson; Qun Liu; Chun-Su Yuan; Chong-Zhi Wang
Journal:  Am J Chin Med       Date:  2015-06-28       Impact factor: 4.667

4.  Novel coumarin- and quinolinone-based polycycles as cell division cycle 25-A and -C phosphatases inhibitors induce proliferation arrest and apoptosis in cancer cells.

Authors:  Clemens Zwergel; Brigitte Czepukojc; Emilie Evain-Bana; Zhanjie Xu; Giulia Stazi; Mattia Mori; Alexandros Patsilinakos; Antonello Mai; Bruno Botta; Rino Ragno; Denise Bagrel; Gilbert Kirsch; Peter Meiser; Claus Jacob; Mathias Montenarh; Sergio Valente
Journal:  Eur J Med Chem       Date:  2017-04-10       Impact factor: 6.514

5.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

Review 6.  CDC25 phosphatases in cancer cells: key players? Good targets?

Authors:  Rose Boutros; Valérie Lobjois; Bernard Ducommun
Journal:  Nat Rev Cancer       Date:  2007-07       Impact factor: 60.716

7.  Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus.

Authors:  K Nishioka; Y Doki; H Shiozaki; H Yamamoto; S Tamura; T Yasuda; Y Fujiwara; M Yano; H Miyata; K Kishi; H Nakagawa; A Shamma; M Monden
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

8.  Ciclopirox inhibits cancer cell proliferation by suppression of Cdc25A.

Authors:  Tao Shen; Chaowei Shang; Hongyu Zhou; Yan Luo; Mansoureh Barzegar; Yoshinobu Odaka; Yang Wu; Shile Huang
Journal:  Genes Cancer       Date:  2017-03

9.  The G2 checkpoint-a node-based molecular switch.

Authors:  Mark C de Gooijer; Arnout van den Top; Irena Bockaj; Jos H Beijnen; Thomas Würdinger; Olaf van Tellingen
Journal:  FEBS Open Bio       Date:  2017-03-04       Impact factor: 2.693

10.  Knockdown of Cyclin-Dependent Kinase Inhibitor 3 Inhibits Proliferation and Invasion in Human Gastric Cancer Cells.

Authors:  Yan Li; Shan Ji; Li-Ye Fu; Tao Jiang; Di Wu; Fan-Dong Meng
Journal:  Oncol Res       Date:  2016-10-27       Impact factor: 5.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.